JP2007526817A - 外部からの圧反射活性化 - Google Patents
外部からの圧反射活性化 Download PDFInfo
- Publication number
- JP2007526817A JP2007526817A JP2007502055A JP2007502055A JP2007526817A JP 2007526817 A JP2007526817 A JP 2007526817A JP 2007502055 A JP2007502055 A JP 2007502055A JP 2007502055 A JP2007502055 A JP 2007502055A JP 2007526817 A JP2007526817 A JP 2007526817A
- Authority
- JP
- Japan
- Prior art keywords
- baroreflex
- patient
- activation
- electrode
- stimulus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004913 activation Effects 0.000 title claims abstract description 186
- 230000035581 baroreflex Effects 0.000 title claims abstract description 175
- 238000000034 method Methods 0.000 claims abstract description 70
- 238000005259 measurement Methods 0.000 claims abstract description 39
- 230000004044 response Effects 0.000 claims abstract description 24
- 108091008698 baroreceptors Proteins 0.000 claims description 84
- 210000001774 pressoreceptor Anatomy 0.000 claims description 84
- 210000001326 carotid sinus Anatomy 0.000 claims description 65
- 230000036772 blood pressure Effects 0.000 claims description 44
- 210000002216 heart Anatomy 0.000 claims description 34
- 210000004126 nerve fiber Anatomy 0.000 claims description 25
- 210000001715 carotid artery Anatomy 0.000 claims description 23
- 230000000694 effects Effects 0.000 claims description 22
- 238000012546 transfer Methods 0.000 claims description 18
- 230000003213 activating effect Effects 0.000 claims description 17
- 230000000747 cardiac effect Effects 0.000 claims description 17
- 230000006870 function Effects 0.000 claims description 15
- 230000002792 vascular Effects 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 6
- 230000000926 neurological effect Effects 0.000 claims description 5
- 238000002646 transcutaneous electrical nerve stimulation Methods 0.000 claims description 5
- 230000008058 pain sensation Effects 0.000 claims description 4
- 230000004936 stimulating effect Effects 0.000 claims description 4
- 238000012377 drug delivery Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000002106 pulse oximetry Methods 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 4
- 210000001367 artery Anatomy 0.000 description 19
- 210000001168 carotid artery common Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 229920001296 polysiloxane Polymers 0.000 description 16
- 206010019280 Heart failures Diseases 0.000 description 15
- 210000004004 carotid artery internal Anatomy 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 230000000638 stimulation Effects 0.000 description 14
- 206010020772 Hypertension Diseases 0.000 description 12
- 210000003484 anatomy Anatomy 0.000 description 12
- 210000004204 blood vessel Anatomy 0.000 description 12
- 230000003014 reinforcing effect Effects 0.000 description 12
- 210000002376 aorta thoracic Anatomy 0.000 description 11
- 238000002513 implantation Methods 0.000 description 10
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 10
- 210000005036 nerve Anatomy 0.000 description 9
- 210000003270 subclavian artery Anatomy 0.000 description 9
- 210000004556 brain Anatomy 0.000 description 8
- 230000002644 neurohormonal effect Effects 0.000 description 8
- 230000002787 reinforcement Effects 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 230000002526 effect on cardiovascular system Effects 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 210000000269 carotid artery external Anatomy 0.000 description 6
- 230000034994 death Effects 0.000 description 6
- 231100000517 death Toxicity 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 239000007943 implant Substances 0.000 description 6
- 239000011810 insulating material Substances 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000004020 conductor Substances 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 230000004043 responsiveness Effects 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 210000005166 vasculature Anatomy 0.000 description 4
- 206010039897 Sedation Diseases 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 238000009530 blood pressure measurement Methods 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- 239000013536 elastomeric material Substances 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 210000004731 jugular vein Anatomy 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 230000036280 sedation Effects 0.000 description 3
- 210000001321 subclavian vein Anatomy 0.000 description 3
- 210000002820 sympathetic nervous system Anatomy 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 2
- 229920004934 Dacron® Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 210000003403 autonomic nervous system Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000000412 mechanoreceptor Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 108091008709 muscle spindles Proteins 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000035485 pulse pressure Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008700 sympathetic activation Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 206010016803 Fluid overload Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000006690 co-activation Effects 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 238000012978 minimally invasive surgical procedure Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008701 parasympathetic activation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920000052 poly(p-xylylene) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 239000013464 silicone adhesive Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 230000004865 vascular response Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0556—Cuff electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Electrotherapy Devices (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54976004P | 2004-03-02 | 2004-03-02 | |
| PCT/US2005/007237 WO2005084389A2 (en) | 2004-03-02 | 2005-03-02 | External baroreflex activation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007526817A true JP2007526817A (ja) | 2007-09-20 |
| JP2007526817A5 JP2007526817A5 (https=) | 2009-02-26 |
Family
ID=34919535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007502055A Pending JP2007526817A (ja) | 2004-03-02 | 2005-03-02 | 外部からの圧反射活性化 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7499747B2 (https=) |
| EP (1) | EP1742700A4 (https=) |
| JP (1) | JP2007526817A (https=) |
| WO (1) | WO2005084389A2 (https=) |
Families Citing this family (150)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6616624B1 (en) * | 2000-10-30 | 2003-09-09 | Cvrx, Inc. | Systems and method for controlling renovascular perfusion |
| US8131371B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
| US8551069B2 (en) | 2002-04-08 | 2013-10-08 | Medtronic Adrian Luxembourg S.a.r.l. | Methods and apparatus for treating contrast nephropathy |
| US8774922B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods |
| US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
| US7620451B2 (en) | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
| US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
| US7162303B2 (en) | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
| US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
| US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
| US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
| US9308043B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
| US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
| US6978174B2 (en) | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
| US20070135875A1 (en) | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
| US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
| US9308044B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
| US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
| US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
| US9636174B2 (en) | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
| US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
| US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
| US7853333B2 (en) | 2002-04-08 | 2010-12-14 | Ardian, Inc. | Methods and apparatus for multi-vessel renal neuromodulation |
| US7937143B2 (en) | 2004-11-02 | 2011-05-03 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
| FR2877205A1 (fr) * | 2004-11-03 | 2006-05-05 | Luc Quintin | Procede et dispositif de prediction d'evenements medicaux anormaux et/ou d'aide au diagnostic et/ou de monitorage, en particulier pour la determination de la profondeur d'anesthesie |
| JP2006280485A (ja) * | 2005-03-09 | 2006-10-19 | Motoharu Hasegawa | 血圧検出装置、血圧検出方法、血圧検出プログラム及び血圧検出歪みセンサ |
| DE102005031116B4 (de) * | 2005-07-04 | 2012-04-12 | Siemens Ag | Stoßwellensystem |
| US8862243B2 (en) | 2005-07-25 | 2014-10-14 | Rainbow Medical Ltd. | Electrical stimulation of blood vessels |
| US9592136B2 (en) | 2005-07-25 | 2017-03-14 | Vascular Dynamics, Inc. | Devices and methods for control of blood pressure |
| US9642726B2 (en) | 2005-07-25 | 2017-05-09 | Vascular Dynamics, Inc. | Devices and methods for control of blood pressure |
| US9125732B2 (en) | 2005-07-25 | 2015-09-08 | Vascular Dynamics, Inc. | Devices and methods for control of blood pressure |
| US8923972B2 (en) | 2005-07-25 | 2014-12-30 | Vascular Dynamics, Inc. | Elliptical element for blood pressure reduction |
| US9125567B2 (en) | 2005-07-25 | 2015-09-08 | Vascular Dynamics, Inc. | Devices and methods for control of blood pressure |
| US8676330B2 (en) * | 2009-03-20 | 2014-03-18 | ElectroCore, LLC | Electrical and magnetic stimulators used to treat migraine/sinus headache and comorbid disorders |
| US8874205B2 (en) * | 2009-03-20 | 2014-10-28 | ElectroCore, LLC | Device and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation |
| US8874227B2 (en) | 2009-03-20 | 2014-10-28 | ElectroCore, LLC | Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
| US20070232966A1 (en) * | 2005-11-30 | 2007-10-04 | Robert Applebaum | Apparatus for skin and muscle treatment |
| JP2009537281A (ja) * | 2006-05-19 | 2009-10-29 | シーブイレクス インコーポレイテッド | 圧反射活性化と薬物治療を併用した生理反応の特性解析および調節 |
| US20080009916A1 (en) * | 2006-05-19 | 2008-01-10 | Cvrx, Inc. | Applications of heart rate variability analysis in electrotherapy affecting autonomic nervous system response |
| WO2008019483A1 (en) * | 2006-08-14 | 2008-02-21 | Med-El Elektro-Medizinische Geräte Gesellschaft M.B.H. | Implantable medical cuff with electrode array |
| US7797041B2 (en) * | 2006-10-11 | 2010-09-14 | Cardiac Pacemakers, Inc. | Transcutaneous neurostimulator for modulating cardiovascular function |
| US7797046B2 (en) * | 2006-10-11 | 2010-09-14 | Cardiac Pacemakers, Inc. | Percutaneous neurostimulator for modulating cardiovascular function |
| US20080288017A1 (en) * | 2007-02-27 | 2008-11-20 | Cvrx, Inc. | External Baroreflex Activation |
| US20080234779A1 (en) * | 2007-03-20 | 2008-09-25 | Cvrx, Inc. | Minimally invasive intraoperative modulation of patient parameters using baroreflex activation |
| US8828068B2 (en) | 2007-07-17 | 2014-09-09 | Cardiac Pacemakers, Inc. | Systems and methods for local vasoactive response using temperature modulation |
| US8594794B2 (en) | 2007-07-24 | 2013-11-26 | Cvrx, Inc. | Baroreflex activation therapy with incrementally changing intensity |
| WO2009018394A1 (en) * | 2007-07-31 | 2009-02-05 | Schneider M Bret | Device and method for hypertension treatment by non-invasive stimulation to vascular baroreceptors |
| WO2009021535A1 (en) * | 2007-08-14 | 2009-02-19 | Campus Micro Technologies Gmbh | Medical devices, systems and methods for blood pressure regulation |
| US20090093729A1 (en) * | 2007-10-03 | 2009-04-09 | Yunlong Zhang | Devices and Methods for Measurement of Vessel Elasticity and Blood Pressure |
| US8116873B2 (en) * | 2007-12-28 | 2012-02-14 | Cvrx, Inc. | Measurement of patient physiological parameters |
| US8214050B2 (en) | 2007-12-31 | 2012-07-03 | Cvrx, Inc. | Method for monitoring physiological cycles of a patient to optimize patient therapy |
| US8538535B2 (en) | 2010-08-05 | 2013-09-17 | Rainbow Medical Ltd. | Enhancing perfusion by contraction |
| US9005106B2 (en) | 2008-01-31 | 2015-04-14 | Enopace Biomedical Ltd | Intra-aortic electrical counterpulsation |
| US8626299B2 (en) | 2008-01-31 | 2014-01-07 | Enopace Biomedical Ltd. | Thoracic aorta and vagus nerve stimulation |
| US8626290B2 (en) | 2008-01-31 | 2014-01-07 | Enopace Biomedical Ltd. | Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta |
| US8326430B2 (en) * | 2008-06-16 | 2012-12-04 | Cvrx, Inc. | Devices and methods for treatment of heart failure and associated conditions |
| US8401652B2 (en) | 2008-06-16 | 2013-03-19 | Cvrx, Inc. | Devices and methods for treatment of heart failure and associated conditions |
| US8321024B2 (en) | 2008-06-16 | 2012-11-27 | Cvrx, Inc. | Devices and methods for treatment of heart failure and associated conditions |
| US8652129B2 (en) | 2008-12-31 | 2014-02-18 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
| US8224449B2 (en) * | 2009-06-29 | 2012-07-17 | Boston Scientific Neuromodulation Corporation | Microstimulator with flap electrodes |
| US9174065B2 (en) | 2009-10-12 | 2015-11-03 | Kona Medical, Inc. | Energetic modulation of nerves |
| US11998266B2 (en) | 2009-10-12 | 2024-06-04 | Otsuka Medical Devices Co., Ltd | Intravascular energy delivery |
| US8469904B2 (en) | 2009-10-12 | 2013-06-25 | Kona Medical, Inc. | Energetic modulation of nerves |
| US20110118600A1 (en) | 2009-11-16 | 2011-05-19 | Michael Gertner | External Autonomic Modulation |
| US9119951B2 (en) | 2009-10-12 | 2015-09-01 | Kona Medical, Inc. | Energetic modulation of nerves |
| US20160059044A1 (en) | 2009-10-12 | 2016-03-03 | Kona Medical, Inc. | Energy delivery to intraparenchymal regions of the kidney to treat hypertension |
| US8295912B2 (en) | 2009-10-12 | 2012-10-23 | Kona Medical, Inc. | Method and system to inhibit a function of a nerve traveling with an artery |
| US8620425B2 (en) | 2010-04-29 | 2013-12-31 | Medtronic, Inc. | Nerve signal differentiation in cardiac therapy |
| US8423134B2 (en) | 2010-04-29 | 2013-04-16 | Medtronic, Inc. | Therapy using perturbation and effect of physiological systems |
| US8639327B2 (en) | 2010-04-29 | 2014-01-28 | Medtronic, Inc. | Nerve signal differentiation in cardiac therapy |
| CN107007348B (zh) | 2010-10-25 | 2019-05-31 | 美敦力Af卢森堡有限责任公司 | 用于神经调节治疗的估算及反馈的装置、系统及方法 |
| AU2011320117B2 (en) | 2010-10-29 | 2016-03-03 | Cvrx, Inc. | Implant tool and improved electrode design for minimally invasive procedure |
| US8649863B2 (en) | 2010-12-20 | 2014-02-11 | Rainbow Medical Ltd. | Pacemaker with no production |
| US8718763B2 (en) | 2011-01-19 | 2014-05-06 | Medtronic, Inc. | Vagal stimulation |
| US8706223B2 (en) | 2011-01-19 | 2014-04-22 | Medtronic, Inc. | Preventative vagal stimulation |
| US8725259B2 (en) | 2011-01-19 | 2014-05-13 | Medtronic, Inc. | Vagal stimulation |
| US8781583B2 (en) | 2011-01-19 | 2014-07-15 | Medtronic, Inc. | Vagal stimulation |
| US8781582B2 (en) | 2011-01-19 | 2014-07-15 | Medtronic, Inc. | Vagal stimulation |
| US8721557B2 (en) | 2011-02-18 | 2014-05-13 | Covidien Lp | Pattern of cuff inflation and deflation for non-invasive blood pressure measurement |
| US9072433B2 (en) | 2011-02-18 | 2015-07-07 | Covidien Lp | Method and apparatus for noninvasive blood pressure measurement using pulse oximetry |
| US12594418B2 (en) | 2011-03-10 | 2026-04-07 | Electrocore, Inc. | Devices and methods for nerve stimulation |
| US9199082B1 (en) | 2011-07-27 | 2015-12-01 | Cvrx, Inc. | Devices and methods for improved placement of implantable medical devices |
| US8855783B2 (en) | 2011-09-09 | 2014-10-07 | Enopace Biomedical Ltd. | Detector-based arterial stimulation |
| EP2872070B1 (en) | 2011-09-09 | 2018-02-07 | Enopace Biomedical Ltd. | Wireless endovascular stent-based electrodes |
| EP2768443A4 (en) | 2011-10-19 | 2015-06-03 | Sympara Medical Inc | METHODS AND DEVICES FOR TREATING HYPERTENSION |
| US8577458B1 (en) | 2011-12-07 | 2013-11-05 | Cyberonics, Inc. | Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with leadless heart rate monitoring |
| US10188856B1 (en) | 2011-12-07 | 2019-01-29 | Cyberonics, Inc. | Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
| US8600505B2 (en) | 2011-12-07 | 2013-12-03 | Cyberonics, Inc. | Implantable device for facilitating control of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
| US8630709B2 (en) | 2011-12-07 | 2014-01-14 | Cyberonics, Inc. | Computer-implemented system and method for selecting therapy profiles of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
| US8918190B2 (en) | 2011-12-07 | 2014-12-23 | Cyberonics, Inc. | Implantable device for evaluating autonomic cardiovascular drive in a patient suffering from chronic cardiac dysfunction |
| US8918191B2 (en) | 2011-12-07 | 2014-12-23 | Cyberonics, Inc. | Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration |
| US8571654B2 (en) | 2012-01-17 | 2013-10-29 | Cyberonics, Inc. | Vagus nerve neurostimulator with multiple patient-selectable modes for treating chronic cardiac dysfunction |
| US8700150B2 (en) | 2012-01-17 | 2014-04-15 | Cyberonics, Inc. | Implantable neurostimulator for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration |
| US9386991B2 (en) | 2012-02-02 | 2016-07-12 | Rainbow Medical Ltd. | Pressure-enhanced blood flow treatment |
| US9750568B2 (en) | 2012-03-08 | 2017-09-05 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
| CN104271062B (zh) | 2012-03-08 | 2017-07-07 | 美敦力Af卢森堡有限责任公司 | 采用神经调节装置的生物标志物取样和相关系统及方法 |
| US8688212B2 (en) | 2012-07-20 | 2014-04-01 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing bradycardia through vagus nerve stimulation |
| US20140110296A1 (en) | 2012-10-19 | 2014-04-24 | Medtronic Ardian Luxembourg S.A.R.L. | Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods |
| US9770593B2 (en) | 2012-11-05 | 2017-09-26 | Pythagoras Medical Ltd. | Patient selection using a transluminally-applied electric current |
| WO2014068577A2 (en) | 2012-11-05 | 2014-05-08 | Rainbow Medical Ltd. | Controlled tissue ablation |
| US9452290B2 (en) | 2012-11-09 | 2016-09-27 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation |
| US9643008B2 (en) | 2012-11-09 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing post-exercise recovery through vagus nerve stimulation |
| US8923964B2 (en) | 2012-11-09 | 2014-12-30 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation |
| EP3498332B1 (en) | 2013-01-21 | 2021-07-14 | Cala Health, Inc. | Devices for controlling tremor |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| US10076384B2 (en) | 2013-03-08 | 2018-09-18 | Symple Surgical, Inc. | Balloon catheter apparatus with microwave emitter |
| US9643011B2 (en) | 2013-03-14 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmic risk during sleep through vagus nerve stimulation |
| US9345877B2 (en) | 2013-08-05 | 2016-05-24 | Cvrx, Inc. | Adapter for connection to pulse generator |
| US9999773B2 (en) | 2013-10-30 | 2018-06-19 | Cyberonics, Inc. | Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters |
| CN105899166B (zh) | 2013-11-06 | 2018-07-06 | 伊诺佩斯生医有限公司 | 无线型血管内基于支架的电极 |
| US9511228B2 (en) | 2014-01-14 | 2016-12-06 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing hypertension through renal denervation and vagus nerve stimulation |
| CN106456984B (zh) | 2014-02-24 | 2019-07-09 | 元素科学公司 | 体外除颤器 |
| US9950169B2 (en) | 2014-04-25 | 2018-04-24 | Cyberonics, Inc. | Dynamic stimulation adjustment for identification of a neural fulcrum |
| US9409024B2 (en) | 2014-03-25 | 2016-08-09 | Cyberonics, Inc. | Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction |
| US9272143B2 (en) | 2014-05-07 | 2016-03-01 | Cyberonics, Inc. | Responsive neurostimulation for the treatment of chronic cardiac dysfunction |
| US9415224B2 (en) | 2014-04-25 | 2016-08-16 | Cyberonics, Inc. | Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction |
| US9713719B2 (en) | 2014-04-17 | 2017-07-25 | Cyberonics, Inc. | Fine resolution identification of a neural fulcrum for the treatment of chronic cardiac dysfunction |
| US10194979B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
| US10194980B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
| US9980766B1 (en) | 2014-03-28 | 2018-05-29 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for renal neuromodulation |
| WO2015170281A1 (en) | 2014-05-07 | 2015-11-12 | Rainbow Medical Ltd | Controlled tissue ablation techniques |
| AU2015271774B2 (en) | 2014-06-02 | 2020-04-16 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
| US9737716B2 (en) | 2014-08-12 | 2017-08-22 | Cyberonics, Inc. | Vagus nerve and carotid baroreceptor stimulation system |
| US9533153B2 (en) | 2014-08-12 | 2017-01-03 | Cyberonics, Inc. | Neurostimulation titration process |
| US9770599B2 (en) | 2014-08-12 | 2017-09-26 | Cyberonics, Inc. | Vagus nerve stimulation and subcutaneous defibrillation system |
| US10925579B2 (en) | 2014-11-05 | 2021-02-23 | Otsuka Medical Devices Co., Ltd. | Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery |
| US9504832B2 (en) | 2014-11-12 | 2016-11-29 | Cyberonics, Inc. | Neurostimulation titration process via adaptive parametric modification |
| DE102014018683B4 (de) * | 2014-12-18 | 2017-11-02 | miha bodytec GmbH | EMS-Reizstromübertragungselement, sowie mit dem EMS-Reizstromübertragungselement ausgestattetes EMS-Kleidungsstück |
| US20160235329A1 (en) * | 2015-02-13 | 2016-08-18 | The Charles Stark Draper Laboratory, Inc. | Nerve bundle cuff including electrodes and transducers |
| US10383685B2 (en) | 2015-05-07 | 2019-08-20 | Pythagoras Medical Ltd. | Techniques for use with nerve tissue |
| CN119565022A (zh) | 2015-06-10 | 2025-03-07 | 卡拉健康公司 | 用于外周神经刺激以利用可拆卸治疗和监测单元治疗震颤的系统和方法 |
| WO2017023864A1 (en) | 2015-07-31 | 2017-02-09 | Cala Health, Inc. | Systems, devices, and method for the treatment of osteoarthritis |
| CN113559415B (zh) | 2015-08-26 | 2024-06-21 | 元素科学公司 | 可穿戴体外除颤器 |
| EP3352843B1 (en) | 2015-09-23 | 2021-06-23 | Cala Health, Inc. | Device for peripheral nerve stimulation in the finger to treat hand tremors |
| WO2017132067A2 (en) | 2016-01-21 | 2017-08-03 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US11678932B2 (en) | 2016-05-18 | 2023-06-20 | Symap Medical (Suzhou) Limited | Electrode catheter with incremental advancement |
| IL264116B2 (en) | 2016-07-08 | 2024-01-01 | Cala Health Inc | Systems and methods for stimulating n nerves with exactly n electrodes and improved dry electrodes |
| CN109803717B (zh) | 2016-08-25 | 2024-01-09 | 卡拉健康公司 | 通过周围神经刺激治疗心脏机能障碍的系统和方法 |
| US10653513B2 (en) | 2017-02-21 | 2020-05-19 | Vascular Dynamics, Inc. | Baroreceptor testing prior to implantation methods and apparatus |
| EP3606604A4 (en) | 2017-04-03 | 2020-12-16 | Cala Health, Inc. | PERIPHERAL NEUROMODULATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH BLADDER HYPERACTIVITY |
| US11857778B2 (en) | 2018-01-17 | 2024-01-02 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| US12070595B2 (en) | 2018-08-15 | 2024-08-27 | Cvrx, Inc. | Devices and methods for percutaneous electrode implant |
| EP3863511B1 (en) | 2018-10-10 | 2024-10-09 | Element Science, Inc. | Wearable medical device with disposable and reusable components |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| CN111870810A (zh) * | 2020-07-08 | 2020-11-03 | 武汉大学 | 颈动脉窦压力感受器刺激装置 |
| US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
| IL299585A (en) | 2021-12-29 | 2023-07-01 | Cvrx Inc | Devices and methods for activating the baroreflex |
| US12502127B2 (en) | 2022-05-03 | 2025-12-23 | Cvrx, Inc. | External baroreflex activation for assessment and treatment |
| IL320681A (en) * | 2022-11-16 | 2025-07-01 | Cvrx Inc | Needle insertion electrode system |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6073048A (en) | 1995-11-17 | 2000-06-06 | Medtronic, Inc. | Baroreflex modulation with carotid sinus nerve stimulation for the treatment of heart failure |
| US5727558A (en) | 1996-02-14 | 1998-03-17 | Hakki; A-Hamid | Noninvasive blood pressure monitor and control device |
| US6178352B1 (en) | 1999-05-07 | 2001-01-23 | Woodside Biomedical, Inc. | Method of blood pressure moderation |
| US6371922B1 (en) | 2000-04-07 | 2002-04-16 | Cardiac Pacemakers, Inc. | Method for measuring baroreflex sensitivity and therapy optimization in heart failure patients |
| US6522926B1 (en) | 2000-09-27 | 2003-02-18 | Cvrx, Inc. | Devices and methods for cardiovascular reflex control |
| US6985774B2 (en) * | 2000-09-27 | 2006-01-10 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
-
2005
- 2005-03-02 EP EP05724725A patent/EP1742700A4/en not_active Withdrawn
- 2005-03-02 US US11/071,602 patent/US7499747B2/en active Active
- 2005-03-02 JP JP2007502055A patent/JP2007526817A/ja active Pending
- 2005-03-02 WO PCT/US2005/007237 patent/WO2005084389A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1742700A2 (en) | 2007-01-17 |
| WO2005084389A9 (en) | 2006-04-20 |
| US20060293712A1 (en) | 2006-12-28 |
| EP1742700A4 (en) | 2008-05-28 |
| WO2005084389A3 (en) | 2006-11-16 |
| WO2005084389A2 (en) | 2005-09-15 |
| US7499747B2 (en) | 2009-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7499747B2 (en) | External baroreflex activation | |
| US20200114153A1 (en) | Electrode structures and methods for their use in cardiovascular reflex control | |
| EP1487535B1 (en) | Electrode structures for use in cardiovascular reflex control | |
| US20080177365A1 (en) | Method and apparatus for electronically switching electrode configuration | |
| US20080172101A1 (en) | Non-linear electrode array | |
| US20100249874A1 (en) | Baroreflex therapy for disordered breathing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080225 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080225 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090108 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20090108 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20090121 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090123 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090422 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090430 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090522 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090529 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090812 |